A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) ...

MoleMap take high-resolution photos of customers’ bodies to map, diagnose and monitor the development of lesions – in an ...

Like other cancers, melanoma is rising among young adults. It's now the 2nd most common cancer in 15 to 39 year-olds.

Researchers studied the progression-free and overall survival rates of patients with advanced melanoma after cessation of immune checkpoint inhibitor therapy.

A new study led by researchers at Lund University in Sweden reveals that melanoma can, in some cases, be driven by ...

The Christie NHS Foundation Trust together with the Cancer Research UK National Biomarker Centre and The University of ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Pathologists' examinations of tissue samples from skin cancer tumors improved when they were assisted by an AI tool. The ...

Researchers have discovered that the most aggressive melanomas, the deadliest form of skin cancer, overactivate two key ...

Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.

Digital imaging of suspected skin cancers has dramatically cut waiting times for diagnosis and treatment in Nottinghamshire.

The idea that a prolonged interval between diagnosing and treating uveal melanoma can affect prognosis has been at the centre of an active debate.1–5 This issue focuses on a key question for ...